FindTrial
Sign In

Effect of nutritional supplement made from Haldi and Black Pepper to prevent and treat active corona virus infection

Evaluation of effects of Tablet Curcumin and adjuvants in exposed individuals and carriers of corona virus, in terms of changes in acute phase reactants and clinical status over 15 days. - CUR-TREATCoV2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025482
Enrollment
50
Registered
2020-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Use of tablet curcumin 525 mg with black pepper: This study arm will include 50 patients tested positive for corona virus (25 carriers and 25 active cases) Both will be given Tablet cur

Sponsors

Siddhivinayak Pain Relief Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Covid -19 Test Positive

Exclusion criteria

Exclusion criteria: Age less than 18 Patients on Blood Thinners History of bleeding disorders

Design outcomes

Primary

MeasureTime frame
Participantsâ?? blood samples will be tested on day 1 for COVID 19 and acute phase reactants like D Dimer, CRP, LDH, CBC, Ferritin, Troponin, cardiac myoglobin, PT INR and then every 3rd day and/or on appearance of respiratory symptomsTimepoint: 15 days—

Secondary

MeasureTime frame
Participants will be monitored for any complaints related to respiratory tract, e.g. cough fever, breathlessness. At the end of 15 days, participant will again be tested for corona virus ELISA test. Timepoint: 15 days—

Countries

India

Contacts

Public ContactDrKirti S Pawar

Maharashtra University of Health Sciences

kirti.skpawar@gmail.com9822701402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026